A blueprint for high-volume, high-quality lung cancer screening that is detecting cancer earlier—and helping to save lives
Peter Bach, MD
With videoconferencing, text messaging, email, and the good old phone call, a treatment method that “spent many years in the desert” has now reached an oasis of acceptance—and savings may result.
ICUs are expensive, intensivists in short supply. Bringing telemedicine to the ICU may help the situation, but doubts linger about what that will achieve.
When infusion therapy, for example, is given at home—a less costly setting—both patient comfort and health plans’ bottom lines benefit. But if hospitals buy up all the practices, payers may lose the chance to save.
Health reimbursement arrangements (HRAs) have fewer rules, but health savings accounts (HSAs) create more of an incentive to shop for health care.
Chief Justice John Roberts
Court challenges have failed. Repeal bills will be vetoed. The next major chapter in the ACA’s history may depend on who wins the White House next year.
Jonathan Weiner, PhD
Health insurers’ capability to gather and create data far outstrips their ability to analyze the information and put it to use. Progress is being made.
Sanovas’s MicroCam bronchoscope
With low-dose CT screening for lung cancer, now may be the time for a California company’s smaller, possibly less expensive bronchoscopy technology.
Multiple Sclerosis: New Perspectives on the Patient Journey–2019 Update
Summary of an Actuarial Analysis and Report